Environmental, Social And Governance Report

Overview

The report covers the Group's 2024 ESG performance across pharmaceutical distribution and manufacturing. It reports 80.00 tCO2e Scope 1 and 50.00 tCO2e Scope 2 emissions, 398,680 kWh total energy consumption, and 7,368 m3 of water consumption. The Group reports 97 staff, with average training hours of 114.9 hours, and states that no work-related fatalities occurred. It also sets near-term goals to reduce GHG emissions by 5%, hazardous and non-hazardous waste by 10%, energy by 5%, and water consumption by 5% in the following reporting period.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services